In recent years, there has been a substantial increase in the number of reported nutrition-related diseases( Reference Zimmet, Alberti and Shaw 1 , Reference Reddy 2 ). Further, obesity – which is a major risk factor for these diseases – has become a global problem( Reference Poirier, Giles and Bray 3 ). Diets that are high in fat have often been cited as a leading cause for obesity( Reference Chan 4 ). However, dietary fat remains an important source of essential fatty acids and plays a major role in the absorption of nutrients and pharmaceuticals( Reference Porter, Trevaskis and Charman 5 – Reference Carey, Small and Bliss 7 ). Therefore, this has prompted an increase in research efforts to understand how food, particularly fat, is processed and digested within the gastrointestinal (GI) tract( Reference Golding and Wooster 8 ). The physical state of fat has been demonstrated to affect the rate of fat digestion( Reference Seimon, Wooster and Otto 9 , Reference Hussein, Hoad and Stephenson 10 ). Using fat emulsions, the in vivo physical state of fat can be adapted by careful design( Reference Steingoetter, Radovic and Buetikofer 11 ). Therefore, there is keen interest from both physiological and product engineering perspectives in order to gain advanced insight into how fat is transformed during digestion and absorption( Reference Fave, Coste and Armand 6 , Reference McClements, Decker and Park 12 ).
To date, there is a reasonable correlation between in vitro models and in vivo outcomes of fat nutrient sensing( Reference Carey, Small and Bliss 7 , Reference Wooster, Day and Xu 13 – Reference Sek, Porter and Kaukonen 16 ). These models together with extensive in vitro studies have generated a good understanding of how a controlled behaviour of fat within the GI tract can influence both nutrient sensing and uptake in vivo ( Reference Golding, Wooster and Day 17 , Reference Day, Golding and Xu 18 ). However, a complete and direct in vitro–in vivo correlation is often hindered by the limited understanding of how intraluminal processes such as emptying dynamics, trituration and inter-mixing with secretions impact the structure of ingested fat emulsions. Therefore, a reliable and convenient method for the visualisation of fat within the human GI tract is required. MRI is a suitable technique meeting these requirements. MRI methods have been validated for both physiological and clinical measurements of GI function in health and disease states( Reference Marciani 19 , Reference Schwizer, Steingoetter and Fox 20 ). Moreover, a small number of studies have demonstrated the feasibility of MRI to visualise the structural changes of lipid emulsions and their impact on gastric emptying and satiation( Reference Steingoetter, Radovic and Buetikofer 11 , Reference Marciani, Wickham and Bush 21 – Reference Marciani, Wickham and Singh 23 ). Further understanding can be provided by using quantitative MRI methods, which have been acknowledged to be of importance for food science and engineering( Reference Marciani, Ramanathan and Tyler 24 – Reference Le Feunteun and Mariette 27 ). Indeed, relaxation mapping methods have already been utilised for the quantification of gastric secretion( Reference Curcic, Sauter and Schwizer 28 – Reference Hoad, Parker and Hudders 31 ). The water–fat separation method, iterative decomposition with echo asymmetry and least squares estimation (IDEAL) allows for a robust separation of the MR signal into its water and fat components( Reference Reeder, McKenzie and Pineda 32 – Reference Yu, Shimakawa and McKenzie 34 ). Therefore, the IDEAL method can provide the visualisation and quantification of spatial distribution of water and fat in vivo ( Reference Tsao and Jiang 35 ). This enables fat fraction maps to be extracted – that is, images with quantitative information – contrasting the commonly applied qualitative fat-selective imaging strategies. This technique has not been applied to the GI tract so far, and thus is a potentially promising tool to study the spatial distribution and emptying dynamics of total intraluminal content alongside an independent measure of fat. This knowledge may ultimately offer deeper insights into the biophysics of gastric mixing and fat digestion. This in turn may provide the means to further bridge the gap between in vitro models and in vivo studies.
Therefore, the overarching aim of this study was to validate the non-invasive quantification of fat fraction in gastric and duodenal contents by MRI, utilising the water–fat separation method IDEAL. To this end, two lipid emulsions with differing acid stabilities were utilised in order to quantify and assess the dynamic processing of fat within the stomach (phase separation and creaming) and duodenum in a randomised, cross-over, single-blinded study design.
Methods
Fat emulsions
Two types of previously described and tested fat emulsions E1 and E4 were used in this study. The composition and properties of the emulsions are outlined in Table 1 ( Reference Steingoetter, Radovic and Buetikofer 11 ); they were prepared as described in online Supplementary Appendix S1.
Fat fraction maps
In order to compute fat fractions based on chemical shift-induced signal variations, an accurate fat model of rapeseed oil was required. Therefore, a spectral multi-peak fat model of rapeseed oil was generated to quantify the fat peaks using a spectroscopic MR measurement on a 3-Tesla MRI scanner (Ingenia, Philips Healthcare). This fat model was used in the IDEAL reconstruction of all fat fraction maps (online Supplementary Fig. S1).
All MRI data were acquired using a 1·5-Tesla MRI scanner (Achieva, Philips Healthcare), using an abdominal phased array coil (4-channel SENSE body coil; Philips Healthcare) with four elements. In order to acquire the fat fraction maps, IDEAL scans were performed with a multi-point echo sequence. The scanned data were then reconstructed by combining the multiple images acquired at the different echo times using the IDEAL approach( Reference Tsao and Jiang 35 ). In reconstruction, B0 field inhomogeneity, T2* decay and the multi-peak spectral fat model were incorporated. After separating the data into water and fat images using the IDEAL reconstruction, the resulting fat fraction maps were obtained by calculating the ratio of the water and fat images.
Study design
Study population
This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all the procedures involving human subjects were approved by the Ethics Committee of the Canton of Zurich (KEK-ZH-Nr. 2014-0220); the trial was registered at ClinicalTrials.gov with identifier NCT02226029. Written informed consent was obtained from all subjects.
The present study was performed using a randomised, single-blinded, two-armed, cross-over study design. A total of twelve healthy subjects were recruited by advertisement. At an initial screening visit, subject eligibility criteria were assessed. Therefore, those invited to participate had neither current health problems nor a history of GI disease or abdominal surgery (excluding appendectomy or hernia repair). Subjects were also required to provide a negative pregnancy test (if applicable), have a BMI between 18 and 25 kg/m2, be a non-regular smoker, aged between 18 and 50 years and have no contraindication to MRI. All the participants underwent MRI scans of 3 h on two different study days. During each study day, subjects were given one of the two emulsions. Assuming a sd of 1·5 % based on earlier data, we estimated that a total of twelve subjects would be needed to detect a difference of 2 % fat fraction, with a defined power of 0·9. Two computer-generated, permutated blocks of twelve defined the randomisation sequence for all subjects. Blinding of the subjects was ensured, as the emulsions had the same visual appearance.
Measurements
On the study day, subjects arrived in the morning at the MR centre at the University Hospital Zurich after 8 h of fasting. A silicone nasogastric tube (Freka CH 12; Fresenius Kabi) was positioned in the gastric corpus through the nostril of the subject. The subjects were infused with 200 ml (1590 kJ (380 kcal)) of the emulsions within 1 min in order to control for the effect of inter-individual tolerance to texture and taste. End of infusion was taken as starting point t=0 min of gastric emptying. Subjects were positioned into the right decubitus in the MR scanner and were allowed to assume a sitting position outside the scanner during longer scan pauses. In these positions, intragastric gas accumulates in the fundus, which ensures a maintained rate of gastric emptying and distribution despite changes in body position( Reference Steingoetter, Fox and Treier 36 ). The first MRI was acquired before meal infusion in order to obtain the volume of residual stomach content in the fasted state. All other MRI were acquired within scan blocks, which were performed at time points t=0, 10, 20, 30, 45, 60, 90, 120, 150 and 180 min, yielding ten blocks in total. Scans were performed during one breath-hold each, lasting from 5 to 34 s. Fig. 1 shows the timeline of the study day.
Up to five samples of gastric content of 2 ml each were collected via the nasogastric tube between t=0 and 120 min. The aspirated gastric samples (online Supplementary Fig. S2) were used to obtain laboratory fat fractions in order to validate the fat fractions obtained using the MRI method IDEAL. After t=120 min, the nasogastric tube was removed.
In each MRI scan block, four image types were acquired: IDEAL and volume scans were used for obtaining gastric and duodenal content volumes. Fat-selective scans yielded qualitative fat-selective images, which served as a comparator to the quantitative fat fraction maps. High-resolution volume scans were acquired in order to determine the position of the nasogastric tube (online Supplementary Appendix S2).
Fat fraction validation
In vitro
An in vitro validation of the fat fraction measurements obtained by IDEAL was performed. The emulsions were diluted to give a series of nine fat fraction samples between 0 and 20 %. The samples were placed into plastic Falcon® tubes (Corning) and then simultaneously positioned in the MRI scanner to be measured by IDEAL. Mean fat fraction values were calculated within a region of interest (ROI) of 5×5 voxels for each sample and compared with the nominal fat fraction values by Lin’s concordance correlation coefficient r c ( Reference Lin 37 ).
In vivo
The fat fraction measurements provided by IDEAL were validated in vivo with nasogastric aspirates( Reference Marciani, Wickham and Hills 38 ). The tip of the catheter was first identified in the high-resolution volume scan, and then a ROI of 5×5 voxels was chosen at the appropriate position in the corresponding fat fraction map (online Supplementary Fig. S3). The fat fraction of the gastric samples was measured by gravimetric analysis. Each sample was first centrifuged at 4300 g for 5 min (Labofuge 400R; Heraeus Instruments) to enhance the phase separation between the emulsion and gastric juice. If possible, the clear gastric juice part was extracted from the gastric sample in order to minimise the contribution of residual particles to the resulting fat fractions. The weights of all samples and extracted gastric juice parts were determined. Subsequently, the samples were dried in a controlled environment and the weights of all samples were measured again after complete evaporation. Gastric samples that either developed mould during the drying process, contained solid particles or could not be identified in the MRI because of ambiguous detection of the nasogastric tip were excluded from the analysis. Laboratory fat fractions were calculated by obtaining the corresponding weight ratios. IDEAL and laboratory fat fractions were compared against each other by r c .
Data analysis
Fat distribution and emptying
A custom software tool written in MATLAB 2012b (The MathWorks) was used for image segmentation and related volume calculation. Gastric or duodenal total content volumes (TCV), which are defined as content volumes without intraluminal air, were derived by semi-automatic segmenting of the content contours of each volume image( Reference Banerjee, Dixit and Fox 39 ).
Gastric or duodenal fat contents were obtained by applying the contours of the volume images to the fat fraction maps. Fat content volume (FCV) was calculated at each time point by weighting TCV with its corresponding average fat fraction value obtained from the fat fraction maps. Gastric and duodenal TCV and their respective FCV were plotted over time to generate volume emptying curves.
Intragastric emulsion profiles
In order to assess creaming and phase separation of the ingested emulsions, intragastric fat fractions were averaged at each level along the direction of gravity as illustrated in Fig. 2. Using these intragastric emulsion profile plots, the time point of maximum phase separation was defined by the occurrence of a maximum fat fraction (ff max) in the stomach. A data-driven bi-phasic model (online Supplementary Appendix S3) was fitted to these profiles in order to detect (1) the location of phase separation in the distal stomach (x 0), (2) the normalised extent of this phase separation E=x 0/x stomach and (3) the increase or gradient in the fat fraction towards the proximal stomach G (see again Fig. 2). These parameters may be considered as surrogate markers for the degree of phase separation and creaming, respectively. The non-linear least-squares fit was performed in MATLAB 2012b.
Statistics
Statistical analyses were carried out using programme R, version 3.1.3( 40 ). The effects on fat emptying and emulsion profile were tested by linear mixed-effects models using function lmer of R package lme4 (version 1.1–7). The outcome measures TCV, FCV and fat fraction were modelled with subject as a random effect. For the stomach, emulsion, time and fasted content volume (TCV-1) were used as fixed effects, whereas only emulsion was used as a fixed effect for the duodenum. The outcome measures ff max, E and G were modelled with subject as a random effect and emulsion as a fixed effect. Model parameter estimates are presented with 95 % CI.
Results
In total twelve subjects were included in the study for MRI measurements. MRI scans were successfully performed on all the twelve subjects (five men, seven women; mean age: 22·0 (sd 2·0) years; mean BMI: 21·9 (sd 1·5) kg/m2). Gastric image data of three scan blocks and duodenal image data of seven scan blocks were missing because of technical errors. Nevertheless, gastric and duodenal volume curves were successfully determined in all subjects. The nasogastric tube, the emulsions and the breath-holds were well tolerated by all subjects.
Fat fraction validation
Fig. 3(a) depicts the scatterplot of the in vitro MRI measurements (nine data points), which demonstrates the agreement between nominal fat fractions and fat fractions measured by IDEAL. Lin’s concordance correlation coefficient was 1·00 (95 % CI 0·98, 1·00).
The laboratory fat fraction values from gastric content samples were determined from a total of eighty-eight included samples. In total twenty-seven samples were excluded from the analysis; Lin’s concordance correlation coefficient was 0·91 (95 % CI 0·87, 0·94). The agreement between the two measurement methods is presented in the scatterplot of Fig. 3(b).
Fat distribution and emptying
Statistical analyses of emulsion profiles were performed only on those during the time point of maximum phase separation (twenty-four data points). Statistical analyses on emptying were performed on 238 gastric and 233 duodenal observations.
Stomach
The different intragastric stability of the fat emulsions resulted in different structuring of intraluminal content. In the standard qualitative fat-selective images, this was indicated by changes in MR signal intensities, where higher fat contents resulted in brighter signals. Colour coding was applied for the fat fraction maps, where blue and red indicated 0 and 100 % fat fraction, respectively. A direct comparison between the two image types showed that they were in agreement with each other, both depicting the different dynamics of phase layering and revealing the different dynamics of fat structuring (Fig. 4). However, inhomogeneity features such as fat fraction gradients and fat pockets could hardly be identified in the fat-selective images but were obvious in the fat fraction maps.
Typical fat distributions in the stomach of the acid-stable emulsion E1 and the acid-unstable emulsion E4 are depicted in the fat fraction maps in Fig. 5(a). E1 largely maintained its stability throughout the 180-min scanning period. This is demonstrated by the gradual transition of the homogeneous gastric content to the deeper shades of blue, which represent lower fat fractions. Further, this indicates that gastric secretion was continuously released into the stomach and then mixed with gastric content. E4 underwent clear structural changes under gastric conditions, resulting in less homogeneous intragastric fat distributions. Shortly after meal infusion, E4 exhibited creaming, flocculation of fat and separation into two phases. This phase separation occurred as a region of higher fat content developing on top of the remaining gastric content. This bi-phasic fat distribution led to a faster emptying of the lower fat content phase present in the distal stomach. In a few subjects, re-emulsification of the flocculated fat could be observed in the image data.
These observations are nicely reflected in the emulsion profiles. The dynamics of phase separation, including the degree of flocculation and subsequent re-emulsification, varied considerably between subjects, as can be observed in the image series of Fig. 4.
Fig. 5(a) shows the change in the intragastric fat fraction over time in one subject. Both the fat fraction maps and the emulsion profiles nicely reflected the different properties of E1 and E4. Individual emulsion profiles of E4 revealed large differences between the subjects as visualised in Fig. 4. No creaming was observed for E1 with ff max of 21·6 (95 % CI 16·4, 26·4) % and G of 0·1 (95 % CI −0·1, 0·2) %/mm. Creaming was stronger in E4 compared with E1, where ff max was larger by 21·2 (95 % CI 14·8, 28·1) % and G was larger by 0·2 (95 % CI 0·04, 0·3) %/mm. The observed highest degree of creaming – that is, the upper range of ff max – was 68 % in E4. The extent of phase separation E for E1 was small with 0·1 (95 % CI 0·0, 0·3); E4 showed values of E that did not differ compared with E1 (difference: 0·1 (95 % CI 0·0, 0·3)).
The different structuring of intraluminal content described above resulted in different emptying patterns of E1 and E4. Individual gastric emptying curves of TCV and FCV grouped per fat emulsion are presented in Fig. 6. Initial TCV – that is, the content volume directly after meal intake – showed large differences between subjects. This was attributed to the effect of TCV-1 with a difference of 0·9 (95 % CI 0·7, 1·2) ml, rather than the effect of the emulsion type with a difference of −2·2 (95 % CI −13·6, 9·1) ml. Therefore, 1 ml of TCV-1 caused an increase in initial TCV by 0·9 ml, which indicates that most residual gastric content still remained in the stomach after intake. TCV of the acid-stable E1 remained high until the end of the scanning period, supporting the observations for the intragastric fat distribution of continuous and intensive dilution with gastric secretion. In several cases, an increase in TCV was observed where the amount of released secretion exceeded that of gastric content emptying. In contrast, TCV of the acid-unstable E4 revealed a distinct non-linear content emptying pattern with rapid decreases during the scanning period. Consequently, TCV emptying for E1 (17 (95 % CI 12, 22) ml/h) was slower by 40 (95 % CI 33, 48) ml/h compared with E4.
Although gastric content emptying curves exhibited large variations among subjects, which were reflected in the large CI values of TCV, FCV curves of both emulsions decreased steadily and yielded smaller CI values. Fat emptying of E1 was 8·6 (95 % CI 9·5, 7·7) ml/h, which was slower by 2·5 (95 % CI 1·7, 3·3) ml/h compared with E4.
Duodenum
Duodenal fat fractions were lower compared with gastric fat fractions. Similar to the gastric content distributions, duodenal contents for E1 appeared more homogeneous. For E4, the duodenum was irregularly flushed with portions of high fat content from the stomach, as depicted in Fig. 5(b).
Fig. 7 demonstrates the duodenal curves for the measures of TCV and FCV, which exhibited less structure than their gastric counterparts. Time did not significantly predict any of the three measures (TCV: 0·01 (95 % CI −0·01, 0·04) ml/h; FCV: 0·001 (95 % CI −0·001, 0·003) ml/h; fat fraction: 0·0 (95 % CI −0·008, 0·008) %), and was therefore removed as a fixed effect in subsequent models. After initial passage of the emulsion through the duodenum, duodenal fat fraction ranged between 5 and 10 % for E1. Duodenal TCV for E1 was 22 (95 % CI 17, 27) ml, which was larger by 6·3 (95 % CI 3·0, 9·3) ml compared with E4. For duodenal FCV, E1 was 1·7 (95 % CI 1·4, 2·1) ml and also exhibited larger volumes compared with E4 with a difference of 0·5 (95 % CI 0.2, 0.8) ml.
Discussion
This study has demonstrated that with IDEAL it was possible (1) to simultaneously visualise the intragastric and duodenal fat distribution and (2) to quantify the differences in emptying, phase separation and creaming of an acid-stable and acid-unstable emulsion.
The IDEAL method was validated both in vitro and in vivo. The in vitro MR measurements showed an excellent linear dependency and agreement between nominal and IDEAL fat fractions. The in vivo validation measurements using the gastric aspirates, however, resulted in lower Lin’s concordance, exhibiting larger and more varying differences. These differences were caused by the following systematic measurement biases. First, the weight of the emulsifiers was included in the final weight after drying. Experiments confirmed that this caused the slope of the regression line between laboratory and nominal fat fractions to decrease by up to 10 %. Second, experiments further confirmed that gastric juice contained up to 2 % of particles other than water, which also remained as residual weight after drying. At 0 % fat fraction, this overestimated the measured value, therefore causing a positive intercept of the regression line. Finally, the large spread of residuals was due to the measurement procedure. Although only those samples with a clear identifiable catheter tip position were included in the analysis, little deviations from the true location of the sample within the stomach could lead to large measurement errors, especially in inhomogeneous regions or regions close to the gastric wall. Despite all these limitations, the detected in vivo correlation was higher than that previously reported for an inversion-recovery-based MRI quantification method( Reference Marciani, Wickham and Hills 38 ).
The different intragastric stability of the fat emulsions affected the distribution of the intraluminal content, which could be visualised with both fat-selective images and the quantitative fat fraction maps. The two image types revealed similar structuring of fat emulsion and were in general in good agreement with each other. However, the fat-selective images could not reveal all the features of inhomogeneity evident in the fat fraction maps. In contrast to fat-selective images, fat fraction maps allowed an assessment of the degree of phase separation and creaming and the resulting emptying rate of fat content. The stable fat emulsion always showed a homogeneous gastric fat distribution where fat was increasingly diluted with gastric secretion. The unstable fat emulsion showed highly variable gastric fat distributions with associated bi-phasic layering.
The differences in structuring of intragastric content caused by the different intragastric stability of the fat emulsions were also reflected in the emptying patterns. The stable fat emulsion exhibited very slow gastric content emptying among all subjects, whereas the unstable emulsion showed inter-individual bi-phasic emptying patterns with faster emptying of the separating phase of lower fat content. These observations correspond to findings reported from a previous study( Reference Steingoetter, Radovic and Buetikofer 11 ) using the same fat emulsions. Large inter-individual differences were observed for the initial content volumes. However, these were attributed to the residual content volumes in the fasted stomach rather than to the emulsion type.
Owing to the steady emptying pattern of the fat in both emulsions, the emptying was approximated by a linear model. The fat-emptying rate of the unstable emulsion was faster than the stable emulsion by approximately 41 %. This may be due to a larger fat droplet size of the re-emulsified high-fat content phase compared with the artificially small original droplet sizes of the emulsions. Previous data have confirmed that a reduction in droplet size of fat emulsions delays gastric emptying due to more effective lipase activity and increased intestinal sensing and feedback( Reference Seimon, Wooster and Otto 9 ).
The model derived from the observed bi-phasic layering of intragastric content yielded a good fit to the emulsion profiles. Although the degree of phase separation was not different between the emulsions, the acid-unstable E4 exhibited a strong degree of creaming. Maximum fat fraction values were twice as large and had a four times larger gradient. Moreover, large variations in emulsion profiles were observed in E4, indicating inter-individual differences in the composition and acidity of gastric secretion. The fluctuations in the emulsion profiles visible in many profiles may be indicators of flocculation of fat droplets, which affect gastric emptying and satiation as previously shown( Reference Steingoetter, Radovic and Buetikofer 11 ). A thorough analysis on this topic was, however, beyond the scope of this study.
Duodenal emptying curves exhibited less structure than their gastric counterparts; a temporal effect of the curves could not be detected. Although the dynamics of gastric emptying are mainly influenced by content emptying into the duodenum on the one hand and release of gastric secretion on the other hand, duodenal emptying is affected by the incoming content from the stomach, emptying into the small intestine and release of bile. This additional complexity seems to be reflected in the duodenal volume curves that exhibited higher fluctuations than their associated gastric curves. The peaks in duodenal FCV may be partly attributed to changes in the subject’s body position that occurred in between the scans. A sudden shift of high fat content towards the distal part of the stomach could have caused the duodenum to be flushed with high fat content. A thorough analysis on how body position affects duodenal fat volume was beyond the scope of this study.
Duodenal volumes of total content and fat were both larger for the stable emulsion – that is, by a factor of 34 and 30 % respectively – whereas mean fat fractions remained at similar levels. Although the larger duodenal TCV for E1 indicates increased gallbladder secretion due to increased fat sensing, the larger FCV may be explained by a delayed fat transport due to a reduced number of duodenal pressure waves( Reference Seimon, Wooster and Otto 9 ).
Two fat emulsions of highly artificial composition were used in order to validate the quantitative MRI methodology. However, the application of IDEAL is not limited to these emulsion types. The application to other fat emulsions is straightforward by substituting the fat model acquired for the rapeseed oil with the appropriate fat model, offering the possibility to choose from a broad range of vegetable or dairy oils. Problems could, however, arise for solid meals or meals generating solid particles within the GI tract. Solid materials cause signal voids in the MR images, resulting in undetectable intraluminal contents.
A major constraint of this method is the rather long maximum breath-hold time used in the study protocol of 34 s, which currently limits the application to healthy individuals. In the future, under-sampling strategies to accelerate data acquisition will reduce scan duration per breath-hold, enabling studies in patients as well( Reference Tsao and Kozerke 41 ). Instead of reducing the breath-hold time, accelerated data acquisition could also be utilised to cover larger fields of view – for example, subjects with larger waist circumferences – and for simultaneous acquisition of gastric and intestinal data. Images covering the entire intestinal tract are useful to provide additional insights into food transit and fat digestion in the lower GI tract. The feasibility of fat quantification in these parts still needs to be investigated because of two factors: first, lower fat contents due to continuous dilution by gastric and duodenal juice, causing the fat fractions to fall below the limit of detection or accuracy, and, second, the disintegration of fat due to digestive enzymes, causing the fat model to be no longer valid. A spectroscopic approach( Reference Hussein, Hoad and Wright 22 ) could be potentially applied for analysing the fat model and its validation in the lower GI tract.
In conclusion, MRI was validated and applied for quantifying the in vivo processing of fat emulsions in the upper GI tract using the water–fat separation method IDEAL. This not only revealed information about the complexity of food structuring during digestion, but also gave insight into the fate of the fat component with regard to emptying and its characteristics under forces such as trituration and peristaltic activity. These methods have great potential to improve the in vitro–in vivo correlation of current digestive models and to be applied in the process of developing effective functional foods that control energy intake and homoeostasis. Both aspects are of key importance in the field of nutrition-related healthcare and eating disorder treatment.
Acknowledgements
The authors thank Tim J. Wooster for critically reviewing the manuscript and providing essential materials and knowledge for the emulsion formulation and production, Nathalie Scheuble for providing support for in vitro analyses, Martina Bertschinger for her help in emulsion production and supporting medical procedures during the pilot study period and, finally, Vlad Ceregan for assisting during study days.
This work was supported by the Swiss National Science Foundation (SNSF), grant numbers 146409 and 145141. The SNSF had no role in the design, analysis or writing of this article.
D. L., W. S., M. F., S. K. and A. S. designed research; D. L., H. L. P. and J. C. conducted research; H. L. P. screened and recruited subjects; D. L. analysed the data; D. L. and A. S. performed the statistical analyses; D. L., H. L. P., J. C. and A. S. wrote the paper; D. L., W. S., M. F. and A. S. had primary responsibility for final content.
The authors declare that there are no conflicts of interest.
Supplementary Material
For supplementary material/s referred to in this article, please visit http://dx.doi.org/10.1017/S0007114515005188